Structure |
Chemical Name |
CAS |
MF |
|
Rosuvastatin Impurity 105 |
|
|
|
(2R,3R,4R,5S,6R)-2-(acetoxymethyl)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate |
1620758-27-1 |
C31H35ClO11 |
|
Febuxostat Impurity 99 |
|
|
|
Furosemide Impurity 20 |
|
|
|
1-((2S,3S)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-(1-((methyl(3-((2-(methylamino)acetoxy)methyl)pyridin-2-yl)carbamoyl)oxy)ethyl)-1H-1,2,4-triazol-4-ium |
|
|
|
(3R,4R,5S)-ethyl 4,5-diacetamido-3-(pentan-3-yloxy)cyclohex-1- enecarboxylate |
1191921-01-3 |
C18H30N2O5 |
|
Ticagrelor Impurity 109 |
|
|
|
Ticagrelor Impurity 134 |
|
|
|
2-Propenamide, 2-cyano-3-(3,4-dihydroxyphenyl)-N,N-diethyl-, (2E)- |
1217439-96-7 |
C14H16N2O3 |
|
Benzonitrile, 4,4'-[[2,2'-bis(hydroxymethyl)[1,1'-biphenyl]-4,4'-diyl]bis(oxy)]bis- |
2254541-79-0 |
C28H20N2O4 |
|
Benzoic acid, 3-(butylamino)-5-[(butylamino)sulfonyl]-4-phenoxy- |
28469-01-4 |
C21H28N2O5S |
|
Acetamide, N-[9-[[2-(acetyloxy)-1-(hydroxymethyl)ethoxy]methyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]- |
298197-26-9 |
C13 H17 N5 O6 |
|
Topiroxostat Impurity 46 |
|
|
|
Topiroxostat Impurity 43 |
|
|
|
N-(2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)ethyl)-N-methyl formamide |
1643948-40-6 |
C17H25NO3 |
|
Regorafenib Impurity 40 |
|
|
|
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-fluoro-1,4-dihydro-6,8-dimethoxy-4-oxo-, ethyl ester |
2489671-14-7 |
C17H18FNO5 |
|
Bisoprolol Impurity 17 |
109791-19-7 |
C15H23NO5 |
|
Furosemide Impurity 5 |
518336-22-6 |
C12H10ClNO3 |
|
Lumateperone Impurity 2 |
313544-32-0 |
C16H19N3O3 |
|
Pramipexole Impurity 55 |
959012-83-0 |
C8H11NO2 |
|
INDEX NAME NOT YET ASSIGNED |
2438857-80-6 |
C27H22F2N6O5 |
|
Nicergoline Impurity 01 |
|
|
|
impurity 38 |
|
|
|
Benzonitrile, 4-[3-[(acetyloxy)methyl]-4-bromophenoxy]- |
2227126-09-0 |
C16H12BrNO3 |
|
3-Pyridineacrylonitrile, α-(m-chlorophenyl)-β-hydroxy- (8CI) |
18206-80-9 |
C14H9ClN2O |
|
Androsta-3,16-dien-17-ol, acetate, (5α)- (9CI) |
103088-58-0 |
C21H30O2 |
|
1-Naphthalenamine, 1,2,3,4-tetrahydro-N-methyl-4-phenyl-, (1S,4S)- |
91797-61-4 |
C17H19N |
|
2-Pyridineethanamine, N-methyl-N-nitroso- |
32635-81-7 |
C8H11N3O |
|
Peramivir Impurity 45 |
|
|
|
Pentanamide, 5-(diphenylphosphinyl)-N-ethyl- |
2512198-63-7 |
C19H24NO2P |
|
1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylic acid, 2,3,6b,9,10,10a-hexahydro-, ethyl ester, (6bR,10aS)- |
313369-17-4 |
C16H21N3O2 |
|
Ergoline-8-methanol, 10-hydroxy-1,6-dimethyl-, 8-(5-bromo-3-pyridinecarboxylate), (8β)- |
57935-66-7 |
C23H24BrN3O3 |
|
(5S,6S,7S)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(((5-methyl-1,3,4- thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2- ene-2-carboxylic acid 5-oxide |
|
|
|
Ethanone, 2-chloro-1-[3-nitro-4-(phenylmethoxy)phenyl]- |
871266-45-4 |
C15H12ClNO4 |
|
Cisatracurium besylate impurity11 |
|
|
|
(3R,5S,E)-tert-butyl 7-(4-(2-fluorophenyl)-6-isopropyl-2-(N-methyl methylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate |
|
|
|
Acetamide, N-?[4-?[5-?(acetylamino)?-?2-?hydroxyphenoxy]?phenyl]?- |
2575516-61-7 |
C16H16N2O4 |
|
Ganciclovir EP Impurity |
|
|
|
Crisaborole Impurity 15 |
|
|
|
Latamoxef impurity A |
|
|
|
Cefadroxil Impurity C |
79962-91-7 |
C16H17N3O5S |
|
Pralatrexate Impurity 8 |
112408-16-9 |
C8H15NO4 |
|
Pitavastatin Impurity 46 |
|
|
|
Canagliflozin Impurity 46 |
|
|
|
Lenvatinib Impurity 37 |
|
|
|
Sitafloxacin Impurity 20 |
|
|
|
posaconazole impurity 66 |
|
|
|
Dapoxetine impurity 33 |
|
|
|
Budesonide Impurity 4 |
|
|
|
Canagliflozin Impurity 49 |
2243132-56-9 |
C34H35FO11S |
|
Canagliflozin Impurity 55 |
|
|
|
Rosuvastatin Impurity 74 |
|
|
|
Tofacitinib Impurity 106 |
|
|
|
(E)-methyl 3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
|
|
2-フルオロ-4-アセチル-1,1'-ビフェニル |
42771-79-9 |
C14H11FO |
|
4-ヒドロキシベンゼン-1,3-ジメタノール |
2937-60-2 |
C8H10O3 |
|
Oseltamivir Impurity 107 |
|
|
|
Oseltamivir Impurity 66 |
|
|
|
Dapagliflozin Impurity 46 |
|
|
|
Brexpiprazole Impurity ABCDEFGHJKL |
|
|
|
4,4'-(2-ピリジニルメチレン)ビスフェノール |
603-41-8 |
C18H15NO2 |
|
Tazobactam Impurity DBT |
|
|
|
3β-[4-O-[4-O-(2,6-ジデオキシ-β-D-ribo-ヘキソピラノシル)-2,6-ジデオキシ-β-D-ribo-ヘキソピラノシル]-2,6-ジデオキシ-β-D-ribo-ヘキソピラノシルオキシ]-12β,14,16β-トリヒドロキシ-5β-カルダ-20(22)-エノリド |
52589-12-5 |
C41H64O15 |
|
Thiophene, 2-(2-fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]- |
2436275-33-9 |
C18H14FIS |
|
Revefenacin Impurity 2 |
1158699-78-5 |
C14H17NO4 |
|
(R)-2-(4-Methoxyphenyl)-1-methylethanamine |
58993-79-6 |
C10H15NO |
|
N-[5-[(1RS)-2-[benzyl[(1RS)-2-(4-methoxyphenyl)- 1-methylethyl]amino]-1-hydroxyethyl]-2- hydroxyphenyl]formamide |
2514947-17-0 |
C26H30N2O4 |
|
NA |
|
|
|
Cilastatin Impurity H |
|
|
|
(trans, trans)-3,3'-(1,4,7,10-tetraazacyclododecane-1,7-diyl)bis(butane-1,2,4-triol) |
|
|
|
Azelastine Impurity K |
|
|
|
2-アミノ-N-[(1α,4β)-4-ヒドロキシシクロヘキシル]ベンズアミド |
15942-11-7 |
C13H18N2O2 |
|
4-O-(カルボキシメチル)リファマイシン |
13929-35-6 |
C39H49NO14 |
|
ethyl 3,5-bis(benzyloxy)benzoate |
50841-46-8 |
C23H22O4 |
|
(R)-4α-チアゾリジンカルボン酸エチル |
60664-15-5 |
C6H11NO2S |
|
3-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl) amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile |
2504210-48-2 |
C22H23N9O |
|
Faropenem Impurity D |
|
|
|
6β-ブロモペニシラン酸 |
24138-28-1 |
C8H10BrNO3S |
|
Hydroxychloroquine Impurity J |
|
|
|
Levetiracetam Impurity 25 |
|
|
|
Levosimendan Impurity 7 |
|
|
|
Cabozantinib impurity K |
|
|
|
Crisaborole Impurity 8 |
|
|
|
Trifluridine Impurity B |
|
|
|
Rotigotine Impurity |
|
|
|
Olprinone Impurity 2 |
106730-62-5 |
C14H12N4O2 |
|
Nicorandil Impurity F |
|
|
|
Nicorandil Impurity A |
|
|
|
Evogliptin Impurity 1 |
|
|
|
Ondansetron IMpurity 5 |
|
|
|
Plerixafor Impurity 1 |
|
|
|
MeropeneM iMpurity 7 |
|
|
|
Brexpiprazole Impurity 34 |
2247155-42-4 |
C25H27N3O4S |
|
Cabozantinib Impurity 5 |
104330-60-1 |
C11H12FNO3 |
|
Dronedarone Impurity 9 |
|
|
|
Empagliflozin Impurity 58 |
|
|
|
Exemestane Impurity 6 |
14895-71-7 |
|
|
Gadobutrol Impurity 10 |
|
|
|
Linagliptin Impurity 55 |
|
|